SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
bioAffinity Technologies Appoints New Members to Board of Directors
August 19, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Reports Second Quarter 2025 Results
August 15, 2025
 · 
11 min read
Press Releases
bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
August 15, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
August 14, 2025
 · 
6 min read
Press Releases
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
August 14, 2025
 · 
6 min read
Press Releases
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results
July 30, 2025
 · 
5 min read
Press Releases
Case Study: CyPath® Lung Detects Neuroendocrine Tumor Missed by Other Diagnostic Tools
July 24, 2025
 · 
5 min read
Press Releases
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic
July 23, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic
July 16, 2025
 · 
4 min read
Press Releases
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
July 10, 2025
 · 
6 min read
Load More
JOBS